CliffBio
small molecule

ANUSOL HC

HYDROCORTISONE

Loss of exclusivity—loss of exclusivity
CompanySalix Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameANUSOL HC
Active ingredientHYDROCORTISONE
Strength2.5%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJune 1984
Marketing statusRX

More from Salix Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.